Claudine Bruck - 10 Sep 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Claudine Bruck
Issuer symbol
ANVS
Transactions as of
10 Sep 2025
Net transactions value
+$1,000
Form type
4
Filing time
12 Nov 2025, 09:17:18 UTC
Previous filing
22 Nov 2023

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bruck Claudine Director C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN /s/ Claudine Bruck 12 Nov 2025 0001733680

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Options Exercise $1,000 +7,142 +109% $0.1400 13,709 10 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Option Options Exercise $0 -7,142 -100% $0.000000 0 10 Sep 2025 Common Stock 7,142 $0.1400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.